Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Venkat Sethuraman"'
Autor:
Sanhita Sengupta, Ives Ntambwe, Katherine Tan, Qixing Liang, David Paulucci, Emily Castellanos, Joseph Fiore, Stephen Lane, Mariann Micsinai Balan, Kalyanee Viraswami‐Apanna, Venkat Sethuraman, Meghna Samant, Ram Tiwari
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:867-877
This proof-of-concept study retrospectively assessed the feasibility of applying a hybrid control arm design to a completed phase 3 randomized controlled trial (RCT; CheckMate-057) in advanced non-small cell lung cancer using a real-world data (RWD)
Autor:
Venkat Sethuraman, David Henry, Lisa Ying, Xiaodong Li, Jiayin Zheng, Fuyu Song, Na Zeng, Shein-Chung Chow
Publikováno v:
Journal of Biopharmaceutical Statistics. 28:840-856
In recent years, multi-regional clinical trials (MRCT) that conduct clinical trials simultaneously in Asian Pacific region, Europe, and the United States have become very popular for global pharmaceutical development. The main purpose of multi-region
Autor:
Marion L. Vetter, Ricardo Zwirtes, Zubin Bhagwagar, Subasree Srinivasan, Venkat Sethuraman, Tilda Chuang, Tina C. Young, Brendan J. Smyth, Premkumar Narasimhan
Publikováno v:
The Journal of Clinical Pharmacology. 57:1079-1087
A systematic review of the Bristol-Myers Squibb normal healthy volunteers (NHVs) database identified phase 1 trials that included NHVs administered placebo with the aim of characterizing normal inter- and intraindividual safety parameter variability.
Autor:
Venkat Sethuraman, Matthew Hutmacher, Seth Berry, Nitin Mehrotra, Holly Kimko, Michael O'Kelly
Publikováno v:
Journal of Biopharmaceutical Statistics. 27:554-567
The application of modeling and simulation (MS) methods to improve decision-making was discussed during the TrendsInnovations in Clinical Trial Statistics Conference held in Durham, North Carolina, USA on May 1-4, 2016. Uses of both pharmacometric an
Autor:
Wei Zhang, Venkat Sethuraman
Publikováno v:
Journal of Biopharmaceutical Statistics. 21:18-23
In ethnic sensitivity studies, it is of interest to know whether the same dose has the same effect over populations in different regions. Glasbrenner and Rosenkranz (2006) proposed a criterion for ethnic sensitivity studies in the context of differen
Autor:
Horst Schran, Thomas M. Smith, K. Grouss, Venkat Sethuraman, Hagop M. Kantarjian, X Wang, Francis J. Giles, Chiaki Tanaka, Ophelia Q. P. Yin, Lawrence Galitz, Oliver G. Ottmann
Publikováno v:
Clinical Pharmacology & Therapeutics. 87:197-203
This article describes studies that investigated the pharmacokinetics of nilotinib, a highly specific, oral, second-generation BCR-ABL tyrosine kinase inhibitor. After a once- or twice-daily regimen at doses ranging from 50 to 1,200 mg/day in 119 pat
Autor:
Venkat Sethuraman, Qiankun Sun
Publikováno v:
Pharmaceutical Statistics. 8:113-124
The current guidelines, ICH E14, for the evaluation of non-antiarrhythmic compounds require a ‘thorough’ QT study (TQT) conducted during clinical development (ICH Guidance for Industry E14, 2005). Owing to the regulatory choice of margin (10 ms),
Autor:
Damaraju Raghavarao, Venkat Sethuraman
Publikováno v:
Journal of Biopharmaceutical Statistics. 19:332-344
In this article we focus on the optimal factorial and fractional-factorial designs when observations within blocks are correlated. The topic was motivated by a problem when the pharmaceutical experimenter needed to develop a controlled release, once-
Autor:
Neil Gallagher, Chiaki Tanaka, Douglas M. Heuman, Ophelia Q. P. Yin, Deirdre Fisher, Venkat Sethuraman, Horst Schran, Tsu-Han Lin, Wei Zhou
Publikováno v:
Clinical Therapeutics. 31:2459-2469
Background: Nilotinib is a second-generation BCR-ABL tyrosine kinase inhibitor approved for the treatment of patients who have imatinib-resistant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic or accelerated phase or who are
Publikováno v:
Seminars in Spine Surgery. 15:411-419
Traditionally, decompressive surgery of the lumbar spine has produced successful results in terms of relieving lower extremity radicular pain. In the setting of degenerative disk disease, decompressive surgery is usually performed for lumbar disk her